The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Ian R. Hardcastle

Northern Institute for Cancer Research University of Newcastle upon Tyne

Newcastle upon Tyne

NE1 4RU

United Kingdom

[email]@ncl.ac.uk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Northern Institute for Cancer Research University of Newcastle upon Tyne, Newcastle upon Tyne, NE1 4RU, United Kingdom. 2002 - 2006
  • Northern Institute for Cancer Research, Bedson Building, School of Natural Sciences, University of Newcastle, UK. 2004 - 2005

References

  1. Small-molecule inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffold. Hardcastle, I.R., Ahmed, S.U., Atkins, H., Farnie, G., Golding, B.T., Griffin, R.J., Guyenne, S., Hutton, C., Källblad, P., Kemp, S.J., Kitching, M.S., Newell, D.R., Norbedo, S., Northen, J.S., Reid, R.J., Saravanan, K., Willems, H.M., Lunec, J. J. Med. Chem. (2006) [Pubmed]
  2. Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction. Hardcastle, I.R., Ahmed, S.U., Atkins, H., Calvert, A.H., Curtin, N.J., Farnie, G., Golding, B.T., Griffin, R.J., Guyenne, S., Hutton, C., Källblad, P., Kemp, S.J., Kitching, M.S., Newell, D.R., Norbedo, S., Northen, J.S., Reid, R.J., Saravanan, K., Willems, H.M., Lunec, J. Bioorg. Med. Chem. Lett. (2005) [Pubmed]
  3. Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach. Hardcastle, I.R., Cockcroft, X., Curtin, N.J., El-Murr, M.D., Leahy, J.J., Stockley, M., Golding, B.T., Rigoreau, L., Richardson, C., Smith, G.C., Griffin, R.J. J. Med. Chem. (2005) [Pubmed]
  4. N2-substituted O6-cyclohexylmethylguanine derivatives: potent inhibitors of cyclin-dependent kinases 1 and 2. Hardcastle, I.R., Arris, C.E., Bentley, J., Boyle, F.T., Chen, Y., Curtin, N.J., Endicott, J.A., Gibson, A.E., Golding, B.T., Griffin, R.J., Jewsbury, P., Menyerol, J., Mesguiche, V., Newell, D.R., Noble, M.E., Pratt, D.J., Wang, L.Z., Whitfield, H.J. J. Med. Chem. (2004) [Pubmed]
  5. Designing inhibitors of cyclin-dependent kinases. Hardcastle, I.R., Golding, B.T., Griffin, R.J. Annu. Rev. Pharmacol. Toxicol. (2002) [Pubmed]
 
WikiGenes - Universities